CIDP and Disability Benefits

Chronic inflammatory demyelinating polyneuropathy, or CIDP, affects peripheral nerves and can cause weakness and sensory difficulties. The course may be persistent or relapsing. A useful disability record explains function over time, including what changes with treatment, rather than relying on one examination during an improved period.

How SSA Evaluates Peripheral Nerve Impairment

Adult listing 11.14 addresses peripheral neuropathy. It includes defined severe motor limitations or combined physical and mental limitations. The diagnosis, an abnormal nerve study or receipt of infusion treatment does not alone establish every listing requirement.

If the condition does not meet or medically equal a listing, SSA evaluates residual functional capacity. Explain all documented limitations together, including effects on walking, hand use, sustained activity and other relevant work demands.

Show the Diagnosis and the Course

• Identify the treating neurologist and clinical findings supporting CIDP.
• Include nerve-conduction and electromyography reports, and other diagnostic testing when performed.
• Provide serial examinations showing strength, sensation, reflexes and changes in mobility or hand function.
• Record relapses, treatment changes and periods of improvement with dates where possible.

Distinguish observations from interpretations. “My legs felt weaker before the next visit” is an account to discuss with the clinician, not proof of a particular disease mechanism. Keep the clinical explanation separate from your own timing notes.

Describe Treatment Cycles Accurately

Clinical approaches may include corticosteroids, other immune-directed medicines, immune globulin or plasma exchange. Selection and monitoring depend on the individual. This page does not recommend a treatment or imply that every person needs the same sequence.

If you receive repeated treatment, record appointment time, recovery, benefit and actual side effects. If functioning changes across the interval, describe the pattern without assuming that it occurs in everyone. Note delays caused by access, authorization or other barriers, and identify the efforts made to obtain prescribed care.

A gap in care needs an explanation, including cost, unavailable appointments or adverse effects. SSA’s failure-to-follow-prescribed-treatment rule applies only in defined circumstances: the person would otherwise qualify, their own medical source prescribed treatment, and they did not follow it. SSA then considers whether it would restore the ability to perform substantial gainful activity and whether there was good cause. A missed visit alone does not answer those questions.

Connect the Timeline to Ordinary Tasks

Explain balance, transfers, walking, handling small items and other activities affected in your case. A hypothetical person may walk a short distance with a device but need help carrying objects at the same time. Describe the combined task, support and frequency rather than treating walking and hand use as unrelated abilities.

Include modified duties or reduced hours and whether they allowed reliable performance. When preparing an appeal, check whether SSA had records spanning the treatment course and understood the duties of your jobs. Follow the notice’s appeal instructions and provide relevant new evidence.

Does a Better Examination After Treatment Settle the Claim?

It is relevant evidence, but the record should explain whether improvement lasts and what limitations remain. Include both better and worse periods, with medical follow-up and honest descriptions of support and activity.

Applications and Approval Data

This guide concerns adult claims. SSA generally requires a medically established impairment that prevents substantial gainful activity for at least 12 continuous months, is expected to do so, or is expected to result in death. SSDI also has insured-work requirements; SSI has financial and other eligibility rules. Childhood disability rules differ.

CIDP is not interchangeable with every neuropathy or with acute Guillain-Barré syndrome. Broad diagnostic totals and use of a particular therapy do not establish a personal approval probability. See how disability approval statistics are defined.

Use our application guide and medical and work records checklist. If denied, read the notice and its review instructions promptly; our appeals guide explains the process.

Related Reading

Peripheral Neuropathy Evidence and Work Function, or return to the condition directory.

Sources and References

• Chronic inflammatory demyelinating polyneuropathy: MedlinePlus Medical Encyclopedia
• 11.00 Neurological – Adult | Disability | SSA^[1]
• Code of Federal Regulations § 404.1545^[2]
• Part II – Evidentiary Requirements | Disability | SSA^[3]
• SSR 18-3p^[4]
• Appeal a decision we made | SSA^[5]
• Part I – General Information | Disability | SSA^[6]
• Code of Federal Regulations § 404.1520^[7]

General educational information, not individualized medical or legal advice. Treatment decisions belong with your healthcare professional. Disability Benefit Guide USA is not affiliated with the Social Security Administration. Read how our guides are prepared.

Official Sources and References

These SSA.gov links support the explanations above. Official applications, account services, and agency forms are completed through SSA.

1. 11.00 Neurological – Adult | Disability | SSA — SSA.gov
2. Code of Federal Regulations § 404.1545 — SSA.gov
3. Part II – Evidentiary Requirements | Disability | SSA — SSA.gov
4. SSR 18-3p — SSA.gov
5. Appeal a decision we made | SSA — SSA.gov
6. Part I – General Information | Disability | SSA — SSA.gov
7. Code of Federal Regulations § 404.1520 — SSA.gov